Search
There were a total of 58 results for your search.
Pirbright awarded a BBSRC Impact Acceleration Account
Pirbright has been awarded £100,000 to support innovative research and promote knowledge exchange. This funding was given by UK Research and Innovation (UKRI) in its Impact Acceleration Account (IAA...
Type: News
Disease Detectives
Have you got what it takes to become a Disease Detective? Pandemic preparedness: why scientists are key Discover how emerging diseases are spread and how research helps to prevent and contain them...
Type: Page
Viral Stress Responses
Our group The Viral Stress Responses group lead by Prof Nicolas Locker studies the molecular mechanism underpinning how biocondensates or phase-separated organelles contribute to how cells respond...
Type: Research group
Pirbright scientists identify mutation hotspots that may inform infectious bronchitis vaccine development
Scientists at The Pirbright Institute have shown that infectious bronchitis virus (IBV) vaccines produced in eggs have unpredictable mutations which may be prone to reversion in the field. IBV causes...
Type: News
Pirbright’s award winning COVID-19 response
The Pirbright Institute has been announced as the winner of the Higher Education Business Continuity Network (HEBCoN) COVID-19 Pandemic Response (CPR) award. The Institute is one of five winning...
Type: News
Seminars
The Pirbright Seminar Series takes place on Thursday afternoons in the Centre for Collaborative Learning at Pirbright. Extra seminars are sometimes scheduled at late notice; please contact the...
Type: Page
Science Spotlight: Promoting women scientists in the fight against COVID-19
To highlight the essential role women are playing in progressing crucial COVID-19 research, the Permanent Mission of Greece to the UN, the Permanent Mission of Lebanon, with the support of the...
Type: News
Research could lead to low cost infectious bronchitis vaccine production
Infectious bronchitis is the most economically important infectious disease affecting chickens in the UK, and remains a major problem in the global poultry industry despite the existence of many...
Type: News
New Animal Vaccine Manufacturing and Innovation Centre to be established at Pirbright
A landmark global health declaration by G7 leaders, which was agreed at the G7 meeting in Carbis Bay, includes a commitment to ensure that the global devastation caused by COVID-19 is never repeated...
Type: News
Why vaccines matter in the fight against zoonotic diseases
On World Zoonoses Day, Pirbright's Professor Munir Iqbal and Dr Joshua Sealy consider 600 years of developing technology to fight infectious diseases: The history of human and animal immunisation...
Type: News